Nicotinamide Phosphoribosyltransferase in Human Diseases.
about
Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic healthNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraNAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease.NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritisNAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the NucleusAssociation of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.Stimulation of MMP-1 and CCL2 by NAMPT in PDL cells.Nampt is involved in DNA double-strand break repair.Regulation of regenerative periodontal healing by NAMPTObesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.Regulation of NAMPT in human gingival fibroblasts and biopsiesHepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis.MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase.Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines.Serum from calorie-restricted animals delays senescence and extends the lifespan of normal human fibroblasts in vitro.Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension.Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages.Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritis.NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis.Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.Regulation of visfatin by microbial and biomechanical signals in PDL cells.NAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation.Visfatin: New marker of oxidative stress in preterm newborns.Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice.Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment.Chicken Is a Useful Model to Investigate the Role of Adipokines in Metabolic and Reproductive Diseases.Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement
P2860
Q26765492-59C58824-D221-4A58-BEFB-92EA43CC5081Q28730781-12CE2380-626B-427C-A600-7E2F3408A075Q30366556-3380C957-2A53-4303-9878-85A933C9D8AAQ33583816-E14912C3-4E8A-46C0-89BA-065D32A01591Q34929150-12220426-9EEF-4712-BBCE-239398DCF86FQ35135460-C154BC65-E3DA-46BD-BDEF-12D6726ED501Q35805959-E2A383A6-6718-41BB-882C-21E46091C6E4Q36184224-A4348816-7635-420B-BC82-8063932EC8C7Q36739012-5075B4C0-9823-4962-A009-74219BD2B3E8Q37154902-10FF586F-8EC6-431B-8552-AA67A926DCAFQ37183754-F36E7230-991A-4185-822B-6601C68AD3FCQ37316433-838B498E-6206-4382-B3D1-7E5AF333DAABQ37527738-E6CD4A36-D8DC-42F9-BDCA-7547E487B535Q37527743-02E64095-9D08-48BA-B3D7-229C9953DBE1Q37636366-438B5365-F3E2-4698-A471-CB1F4DE85ED1Q37670328-24CA03D9-A3A3-4918-858A-C693ABE20F0DQ37691630-5BD5B862-6911-493A-A31F-4EAF39E226ACQ37745422-BCA9061D-52C0-4C0E-9A8A-BD2ED6406F33Q38736710-2CE4A187-AC2C-4ED7-92EA-900FBE2DB9DCQ38889552-828317CF-9D56-4ABC-A0B7-778E12339B8DQ38928592-C151A59B-9EB5-43D6-8985-A417E8F58974Q38959459-21EE267B-AB54-4682-A5B5-7F78E4E0A563Q39123521-13F133F4-7C67-4197-AA0B-07826AD1B94CQ39274448-8F2FA061-D004-4EA8-B4E1-AE549D1C5D60Q41348313-9AE6D999-B8E9-45AC-A9BA-95A09DD27E1DQ41583248-D086EFD0-CC86-418F-B8CD-CDCA3616461CQ45950376-C0890CE8-2107-4CBC-8F32-E55EBED9AECAQ46072505-9CDE9A8A-710C-4C56-A748-FAD5B6A51980Q46275764-199E978A-67A7-461B-8F1A-24B50170F5C7Q46645132-E2FEB389-168B-43F5-ABDE-17B798FA49E8Q49921071-DF253A04-FC8B-457C-9290-2749F7599234Q52717424-6008197C-5C1E-4DD6-8780-BF47A4541EABQ53694785-948D120F-067F-441B-9A82-BC4681A49C12Q55690183-FD76B637-84A4-46DC-8360-09B5A75FE946Q58044476-C3657067-5151-441C-A0C2-BEFF521AE537
P2860
Nicotinamide Phosphoribosyltransferase in Human Diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@ast
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@en
type
label
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@ast
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@en
prefLabel
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@ast
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@en
P2093
P2860
P1476
Nicotinamide Phosphoribosyltransferase in Human Diseases.
@en
P2093
Daniel P Heruth
Li Qin Zhang
Shui Qing Ye
P2860
P356
10.4172/1948-593X.1000038
P577
2011-01-01T00:00:00Z